Elevated plasma CXCL12/SDF-1 levels are linked with disease severity of postmenopausal osteoporosis

Elevated plasma CXCL12/SDF-1 levels are linked with disease severity of postmenopausal osteoporosis

This study was designed to determine whether plasma CXCL12 levels in postmenopausal osteoporosis (PMOP) patients are related to disease severity. A total of 91 PMOP females were recruited, and 88 postmenopausal non-osteoporotic (PMNOP) women and 90 healthy females were incorporated as controls. Dual...

Full description

Bibliographic Details
Main Authors:	Xian-Wen Yang, Hong-Xing Huang, Fei Wang, Qi-Lin Zhou, Yan-Qiang Huang, Ru-Zi Qin
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-04-01
Series:	Innate Immunity
Online Access:	https://doi.org/10.1177/1753425919883365

Similar Items

CXCL12/SDF-1 and CXCR4
by: Takashi eNagasawa
Published: (2015-06-01)

Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.
by: Jason A Wojcechowskyj, et al.
Published: (2011-01-01)

CXCL12/SDF-1 facilitates optic nerve regeneration
by: Annemarie Heskamp, et al.
Published: (2013-07-01)

SDF-1/CXCL12: A chemokine in the life cycle of HIV
by: Fernando eArenzana-Seisdedos
Published: (2015-06-01)

Serum level of SDF-1α (CXCL12) in chemical victims with respiratory complications
by: F. Ayubi, et al.
Published: (2014-03-01)

Correlation of SDF-1/CXCL12 Expression with Immune Cell Infiltration in Cervical Cancer
by: Jaafar, Hajah Siti Fatimah
Published: (2009)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
by: Liu Z, et al.
Published: (2020-07-01)

Role of STAT3 and SDF-1/CXCL 12 in mitochondrial function in hematopoietic stem and progenitor cells
by: Messina-Graham, Steven V.
Published: (2016)

Serum CXCL12/SDF-1 level is positively related with lumbar intervertebral disc degeneration and clinical severity
by: Zhao-Juan Er, et al.
Published: (2020-07-01)

Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
by: Reckamp Karen, et al.
Published: (2006-11-01)

Investigation of regulatory mechanism of chemokine CXCL12/SDF-1 in adult hematopoietic stem/progenitor cells homeostasis
by: Yi--Shiuan Tzeng, et al.
Published: (2010)

Plasma leptin values in postmenopausal women with osteoporosis
by: Hikmet Kocyigit, et al.
Published: (2013-08-01)

Concentration of stromal cell‐derived factor‐1 (SDF‐1/CXCL12) in the follicular fluid is associated with blastocyst development
by: Akemi Nishigaki, et al.
Published: (2019-04-01)

Erratum to “CXCL12/SDF-1 facilitates optic nerve regeneration” [Neurobiol. Dis. 55 (2013) 76–86]
by: Annemarie Heskamp, et al.
Published: (2013-10-01)

Lipid profile and plasma atherogenic index in postmenopausal osteoporosis
by: Gulcin Sahin Ersoy, et al.
Published: (2017-11-01)

Primary osteoporosis in postmenopausal women
by: Meng-Xia Ji, et al.
Published: (2015-03-01)

Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg Ischaemia
by: Teik K. Ho, et al.
Published: (2012-01-01)

MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells.
by: Manoj M Pillai, et al.
Published: (2010-12-01)

Expression von SDF-1/CXCL12 und CXCR4 in der sequenziellen DMBA-induzierten Karzinogenese des Hamsters
by: Nadenau, Eva
Published: (2015)

Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension.
by: Brian N McCullagh, et al.
Published: (2015-01-01)

Hypercalciuria in Postmenopausal Osteoporosis
by: Ayfer Kanberoğlu, et al.
Published: (2004-06-01)

The treatment of postmenopausal osteoporosis
by: Middleton, Edward Thomas
Published: (2008)

Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)

BREASTFEEDING AND POSTMENOPAUSAL OSTEOPOROSIS
by: Horia Lăzărescu, et al.
Published: (2019-09-01)

Botanicals in Postmenopausal Osteoporosis
by: Wojciech Słupski, et al.
Published: (2021-05-01)

Etude des mécanismes d'action de CXCL12a (SDF-1gas) sur les cardiomyocytes néonataux de rats
by: Hadad, Ielham
Published: (2015)

Chemotactic TEG3 Cells’ Guiding Platforms Based on PLA Fibers Functionalized With the SDF-1α/CXCL12 Chemokine for Neural Regeneration Therapy
by: Oscar Castaño, et al.
Published: (2021-03-01)

Postmenopausal osteoporosis: Our experience
by: R N Mehrotra, et al.
Published: (2012-01-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

HYPERTENSION AND OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Marina Rašić Popović, et al.
Published: (2009-04-01)

Immunologic Aspects of Postmenopausal Osteoporosis
by: V.V. Povoroznyuk, et al.
Published: (2013-08-01)

Bazedoxifene for the prevention of postmenopausal osteoporosis
by: Luigi Gennari, et al.
Published: (2008-09-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Treatment options for postmenopausal osteoporosis
by: Walsh GM
Published: (2012-08-01)

Genetic epidemiology of postmenopausal osteoporosis
by: Keen, Richard William
Published: (2000)

Association between Postmenopausal Osteoporosis and Experimental Periodontitis
by: Kai Luo, et al.
Published: (2014-01-01)

The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury
by: Walker Aisha L, et al.
Published: (2005-10-01)

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
by: Ishikawa K, et al.
Published: (2016-12-01)

Functional characterization of CXCL12 and CXCL14 in the ovary
by: Sheng-Wen Wang, et al.
Published: (2014)

Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
by: Yi‐ran Yang, et al.
Published: (2019-12-01)